PD-Rx Pharmaceuticals, Inc. (PDRX)

OTCMKTS · Delayed Price · Currency is USD
3.330
+0.430 (14.83%)
At close: Jan 12, 2026
33.20%
Market Cap5.48M
Revenue (ttm)18.35M
Net Income (ttm)-257.52K
Shares Out1.64M
EPS (ttm)-0.16
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,411
Average Volume1,453
Open3.250
Previous Close2.900
Day's Range3.250 - 3.330
52-Week Range2.410 - 3.330
Beta1,654,528.56
RSI58.29
Earnings DateNov 20, 2025

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to trac... [Read more]

Sector Healthcare
Founded 1986
Employees 28
Stock Exchange OTCMKTS
Ticker Symbol PDRX
Full Company Profile

Financial Performance

In 2025, PD-Rx Pharmaceuticals's revenue was $18.35 million, a decrease of -3.15% compared to the previous year's $18.95 million. Losses were -$257,523, -65.82% less than in 2024.

Financial Statements